Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain
- 15 September 1994
- Vol. 74 (6), 1808-1816
- https://doi.org/10.1002/1097-0142(19940915)74:6<1808::aid-cncr2820740625>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Putative role of hydromorphone metabolites in myoclonusPain, 1992
- Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgiaNeurology, 1991
- Clinical analgesic assay of repeated and single doses of heroin and hydromorphonePain, 1990
- Hydromorphone levels and pain control in patients with severe chronic painClinical Pharmacology & Therapeutics, 1988
- Absolute Bioavailability of Hydromorphone After Peroral and Rectal Administration in Humans: Saliva/Plasma Ratio and Clinical EffectsThe Journal of Clinical Pharmacology, 1987
- Epidural HydromorphoneAnesthesiology, 1987
- EFFECTS OF EPINEPHRINE ON EPIDURAL FENTANYL, SUFENTANIL AND HYDROMORPHONE FOR POSTOPERATIVE ANALGESIAAnesthesiology, 1985
- Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human SubjectsThe Journal of Clinical Pharmacology, 1981
- Relative Analgesic Potencies of Morphine and Hydromorphone in Postoperative PainAnesthesiology, 1975
- AN Evaluation OF DIHYDROMORPHINONE* IN TREATING POSTOPERATIVE PAINAnesthesia & Analgesia, 1962